We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simple Breath Test Aids Type 1 Diabetes Early Diagnosis

By LabMedica International staff writers
Posted on 08 Dec 2014
Print article
Image: The AirSense is a mass spectrometer based on the patented Ion-Molecule Reaction (IMR-MS) and can be used for a broad field of applications (Photo courtesy of V&F).
Image: The AirSense is a mass spectrometer based on the patented Ion-Molecule Reaction (IMR-MS) and can be used for a broad field of applications (Photo courtesy of V&F).
A chemical marker has been identified for type 1 diabetes in the breath of children who are unaware they have the condition until they develop diabetic ketoacidosis, a potentially life-threatening complication and a breath test could pave the way to allow early diagnosis.

The symptoms of the diabetes mellitus type 1, which include increased thirst and urination, fatigue and weight loss, can be mistaken for symptoms of other disorders and some cases where type 1 diabetes is misdiagnosed in children. A recent study found that between 2001 and 2009, incidence of type 1 diabetes among children aged less than 9 years rose by 21%.

Biochemists at the University of Oxford (UK) collected breath samples from 113 children and adolescents aged 7 to 18 years that had been diagnosed with type 1 diabetes. The team measured levels of acetone and another ketone called isoprene in the participants' breath and compared them with ketone and glucose levels in the blood, measurements of which were taken at the same time as breath samples were collected.

The patients blew through a tube and a bacterial filter into a specially constructed 100 mL syringe which had the aim of ensuring that the gases collected were end tidal. The sealed bags were analyzed by means of a soft-ionization mass spectrometer (V & F Airsense; Absam, Austria). Acetone, isoprene and carbon dioxide concentrations were measured, with the instrument standardized for its sensitivity to these compounds by using previously calibrated gas samples. Each patient provided blood for an HbA1c measurement and had capillary blood glucose and β hydroxybutyrate (BHB) levels measured using a FreeStyle Optium meter (Abbott, Maidenhead, UK).

The investigators found increased levels of acetone in the breath of the participants who also had increased levels of a ketone called β hydroxybutyrate in their blood. The team found a weak association between increased breath acetone and increased blood glucose but concluded that single breath measurements of acetone do not provide a good measure of blood glucose levels in this cohort. The team has already produced a prototype of a small hand-held device to measure ketone levels in the breath, which is currently being tested in clinical trials.

Gus Hancock, PhD, a professor of chemistry and a senior author of the study said, “Our results have shown that it is realistically possible to use measurements of breath acetone to estimate blood ketones. If the relationship between breath acetone and blood ketone levels is true at higher levels of ketones, a simple breath test could assist with the management of sick days in children with diabetes, preventing hospital admissions by providing a warning of the possible development of diabetic ketoacidosis (DKA).” The study was published on November 25, 2014, in the Journal of Breath Research.

Related Links:

University of Oxford
V & F Airsense
Abbott 


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.